Improving surveillance for Barrett's oesophagus - AspECT and BOSS trials provide an evidence base

被引:36
作者
Jankowski, J [1 ]
Barr, H
机构
[1] Univ Oxford, Dept Clin Pharmacol, Oxford OX2 6HE, England
[2] Gloucestershire Royal Hosp, Dept Surg, Gloucester GL1 3NN, England
来源
BRITISH MEDICAL JOURNAL | 2006年 / 332卷 / 7556期
关键词
D O I
10.1136/bmj.332.7556.1512
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:1512 / 1512
页数:1
相关论文
共 3 条
[1]  
BAMPTON PA, 2005, BRIT MED J, V332, P1390
[2]   Re: Cost-effectiveness of aspirin chemoprevention for Barrett's esophagus [J].
Jankowski, J ;
Moayyedi, P .
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2004, 96 (11) :885-887
[3]   A methodologic analysis of chemoprevention and cancer prevention strategies for gastrointestinal cancer [J].
Jankowski, JA ;
Hawk, ET .
NATURE CLINICAL PRACTICE GASTROENTEROLOGY & HEPATOLOGY, 2006, 3 (02) :101-111